Table: Jcr Pharmaceuticals -2023/24 parent results

JCR Pharmaceuticals

26/06/2024 08:00

Jun 26 (Reuters)- 
          Jcr Pharmaceuticals Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             42.87           34.34                                
                 (+24.8 pct)     (-32.8 pct)                             
  Operating          7.55            5.10                                
                 (+48.2 pct)     (-74.7 pct)                             
  Recurring          8.05            5.28                                
                 (+52.3 pct)     (-74.1 pct)                             
  Net                6.36            3.69                                
                 (+72.6 pct)     (-74.5 pct)                             
  EPS             51.00 yen       29.67 yen                              
  EPS Diluted     50.76 yen       29.54 yen                              
  Ann Div         20.00 yen       20.00 yen      20.00 yen               
  -Q2 Div         10.00 yen       10.00 yen      10.00 yen               
  -Q4 Div         10.00 yen       10.00 yen      10.00 yen               
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T